Mesothelin-Targeted Immunotoxin LMB-100 in People With Malignant Mesothelioma (Q66401890)
Jump to navigation
Jump to search
clinical trial
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Mesothelin-Targeted Immunotoxin LMB-100 in People With Malignant Mesothelioma |
clinical trial |
Statements
A Phase I Study of the Mesothelin-Targeted Immunotoxin LMB-100 With or Without Nab-Paclitaxel (Abraxane) in Patients With Malignant Mesothelioma (English)
0 references
10 June 2016
0 references
20 July 2017
0 references
21
0 references
18 year
0 references
100 year
0 references